Traditional Chinese medicine active ingredient compound preparation for treating vascular dementia and application thereof

A technology for vascular dementia and active ingredients, applied in the field of traditional Chinese medicine, can solve the problems of increased blood drug concentration and low oral bioavailability, and achieve the effects of slowing down the metabolism of acetylcholine, alleviating cognitive dysfunction, and reducing drug dosage.

Active Publication Date: 2020-07-17
GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although ginsenosides Rg3, Rg1, Re, Rf, and Rg2 have no significant increase in blood drug concentration after continuous administration [13], ginsenosides Rg1 and Re have the effect of protecting learning and memory, but ginsenosides Rg1, Rg3, and Re are easy to Degraded by enzymes produced by intestinal bacteria, oral bioavailability is very low [14-16]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine active ingredient compound preparation for treating vascular dementia and application thereof
  • Traditional Chinese medicine active ingredient compound preparation for treating vascular dementia and application thereof
  • Traditional Chinese medicine active ingredient compound preparation for treating vascular dementia and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] A compound preparation of active ingredients of traditional Chinese medicine for the treatment of vascular dementia. The compound preparation includes effective ingredients and / or pharmaceutically acceptable excipients or carriers. The effective ingredients are composed of ginsenoside Rb3 and β-asarone, and the effective The ingredients consist of 1-5 parts by weight of ginsenoside Rb3 and 1-5 parts by weight of β-asarone.

Embodiment 2

[0076] An oral tablet for the treatment of vascular dementia. The compound preparation includes active ingredients and / or pharmaceutically acceptable excipients or carriers. The active ingredients are composed of ginsenoside Rb3 and β-asarone, wherein the effective ingredients are It is composed of 1 part by weight of ginsenoside Rb3 and 1 part by weight of β-asarone.

[0077] According to the conventional method, the raw and auxiliary materials are mixed, granulated, dried, and compressed.

Embodiment 3

[0079] An oral liquid for the treatment of vascular dementia. The compound preparation includes active ingredients and / or pharmaceutically acceptable excipients or carriers. The active ingredients are composed of ginsenoside Rb3 and β-asarone, and the effective ingredients are composed of 2 It consists of parts by weight of ginsenoside Rb3 and 3 parts by weight of β-asarone.

[0080] Mix the raw and auxiliary materials according to the conventional method to make an oral liquid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of traditional Chinese medicines. The invention particularly discloses a traditional Chinese medicine effective component compound preparation for treatingvascular dementia and an application thereof. The compound preparation comprises effective components and / or pharmaceutically acceptable auxiliary materials or carriers. The compound preparation is characterized in that effective components consist of ginsenoside Rb3 and beta-asarone; and through the synergistic effect of the ginsenoside Rb3 and the beta-asarone, protection on nerve cells is effectively improved; generation of beta-like precipitated proteins and metabolism of acetylcholine are slowed down, damages caused by free radicals, apoptosis factors and the like are reduced, cognitiveimpairment caused by brain tissue apoptosis necrosis is obviously relieved, and cell apoptosis and cell oxidative stress reaction are inhibited. The compound preparation has a remarkable effect of preventing and treating vascular dementia, is less in medicine flavor and clear in action mechanism and is beneficial to quality control, and the medicine dosage is effectively reduced while the curativeeffect is ensured.

Description

Technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a compound preparation for treating vascular dementia and its application. Background technique [0002] Vascular dementia (VaD) is a clinical syndrome of varying degrees from mild cognitive impairment to dementia that occurs on the basis of brain cell function degradation caused by various stroke-related factors [1]. VaD is a common senile disease in my country. The clinical manifestations are mainly memory loss and intelligence decline, accompanied by decreased living ability, abnormal mood and behavior, etc. With the increasing ageing of our country's population and changes in dietary structure and daily life, the incidence of stroke and heart disease is also increasing. In recent years, due to the blowout growth of cerebrovascular diseases, people pay more and more attention to the research of VaD. At present, there are two meanings of post-stroke dementia: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/704A61K31/09A61P25/28
CPCA61K31/09A61K31/704A61P25/28A61K2300/00
Inventor 邓敏贞
Owner GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products